OBO ID: CHEBI:68478

Term Name:	everolimus		Search Ontology:
Synonyms:	(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-hydroxyethyl)rapamycin Afinitor Afinitor Disperz Certican everolimus everolimusum RAD 001 RAD001 SDZ RAD SDZ-RAD Votubia Xience V Zortress
Definition:	A macrocyclic lactone that is rapamycin in which the hydroxy group attached to the cyclohexyl moiety has been converted into the corresponding 2-hydroxyethyl ether. It is an immunosuppressant and antineoplastic agent.
References:	CAS:159351-69-6 Chemspider:21106307 DrugBank:DB01590 Drug_Central:1118 HMDB:HMDB0015529 KEGG:D02714 LINCS:LSM-43172 PMID:22363408 PMID:22404500 PMID:22461124 PMID:22683823 PMID:22967800 PMID:22969095 PMID:22983698 PMID:22986894 PMID:31478889 PMID:33640871 PMID:33986025 PMID:33998365 PMID:34018490 PMID:34225066 PMID:34242751 PMID:34253597 PMID:34299359 PMID:34467233 PMID:34491881 PMID:34527569 Patent:CN102138903 Patent:RU2008143550 Patent:WO2012066502 Wikipedia:Everolimus
Ontology:	ChEBI  ( EBI )